Adherence to rivaroxaban for the treatment of venous thromboembolism-Results from the FIRST registry.

Victoria Speed Vivian Auyeung Jignesh P PatelDerek CooperStephen MillerLara N RobertsRaj K PatelRoopen Arya

Published in: Research and practice in thrombosis and haemostasis (2021)

Overall adherence to rivaroxaban was high, and most nonadherence was unintentional. Identification of those at risk of nonadherence may reduce the risk of VTE recurrence and long-term complications.

Keyphrases

venous thromboembolism
direct oral anticoagulants
risk factors
atrial fibrillation
glycemic control
free survival
metabolic syndrome
bioinformatics analysis